The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
A | Alimentary tract and metabolism | |
2
|
A03 | Drugs for functional gastrointestinal disorders | |
3
|
A03A | DRUGS FOR FUNCTIONAL BOWEL DISORDERS | |
4
|
A03AA | Synthetic anticholinergics, esters with tertiary amino group | |
5
|
A03AA04 | Mebeverine |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Code | Route | Amount | Notes |
|---|---|---|---|
| ORAL | Oral | 0.3 g |
| Active Ingredient |
|---|
|
Mebeverine is a musculotropic antispasmodic with a direct action on the smooth muscle of the gastrointestinal tract, relieving spasm without affecting normal gut motility. |
| Document | Type | Information Source | |
|---|---|---|---|
| AUROBEVERINE Modified-release capsule, hard | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| COLOFAC Coated tablet | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| COLOFAC Modified release capsule | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| DUSPATALIN Modified release capsule, hard | MPI, EU: SmPC | Υπουργείο Υγείας (CY) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.